BRIGIN SEGER: Open Payments
NPI 1770193740 · MT JULIET, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,298 in 65 payments from 16 companies in 2025. Trend: 2023 $2,683 · 2024 $2,666 · 2025 $1,298
Food & beverage: $1,298
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $306 |
| Novo Nordisk Inc | 13 | $243 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $138 |
| Corcept Therapeutics | 5 | $99 |
| ABBVIE INC. | 4 | $87 |
| GlaxoSmithKline, LLC. | 5 | $87 |
| Lilly USA, LLC | 4 | $66 |
| Astellas Pharma US Inc | 3 | $66 |
| Amgen Inc. | 3 | $47 |
| PFIZER INC. | 2 | $40 |
Products named: BREZTRI, CAPLYTA, Ozempic, FARXIGA, Korlym, TRELEGY ELLIPTA, Veozah, Wegovy.
Industry payments across TN — which companies pay providers there.
